| 1. | | Recruiting | Bevacizumab With or Without Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma |
| 2. | | Recruiting | Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 3. | | Recruiting | CCI-779 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm |
| 4. | | Recruiting | Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
Conditions: insular thyroid cancer; recurrent thyroid cancer; stage II follicular thyroid cancer; stage II papillary thyroid cancer; ... |
| 5. | | Recruiting | Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer |
| 6. | | Recruiting | Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
| 7. | | Recruiting | Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 8. | | Recruiting | Flavopiridol, Fludarabine, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Hairy Cell Leukemia |
| 9. | | Recruiting | FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Conditions: gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor |
| 10. | | Not yet recruiting | FR901228 in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
| 11. | | Recruiting | GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Conditions: recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ... |
| 12. | | Recruiting | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
Conditions: recurrent breast cancer; recurrent gastric cancer; recurrent non-small cell lung cancer; recurrent ovarian epithelial cancer; ... |
| 13. | | Recruiting | Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
Conditions: untreated adult acute myeloid leukemia; secondary acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); ... |
| 14. | | Recruiting | Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 15. | | Recruiting | Suramin and Paclitaxel in Treating Women With Stage IIIB or Stage IV Breast Cancer
Conditions: recurrent breast cancer; stage IIIB breast cancer; stage IV breast cancer |
